Float Short %

10.68

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

EPS Last/This Y

0.14

EPS This/Next Y

0.07

Price

1.2

Target Price

3.69

Analyst Recom

1.78

Performance Q

-56.99

Relative Volume

0.69

Beta

0.64

Ticker: GERN

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	GERN	1.315	0.09	0.00	86583
2025-04-15	GERN	1.255	0.09	0.02	86634
2025-04-16	GERN	1.245	0.08	0.37	86992
2025-04-17	GERN	1.275	0.08	0.02	87278
2025-04-18	GERN	1.27	0.08	0.01	87278
2025-04-21	GERN	1.35	0.08	0.01	82904
2025-04-22	GERN	1.405	0.08	0.03	84759
2025-04-23	GERN	1.38	0.08	0.00	85409
2025-04-24	GERN	1.415	0.08	0.00	85963
2025-04-25	GERN	1.42	0.080046418345337	0.050955414012739	85625
2025-04-28	GERN	1.4	0.080555205047319	0.0040899795501022	85634
2025-04-29	GERN	1.385	0.08	0.23	85667
2025-04-30	GERN	1.4	0.08	1.21	86019
2025-05-01	GERN	1.42	0.08	0.04	86089
2025-05-02	GERN	1.36	0.08	0.02	86506
2025-05-05	GERN	1.415	0.08	0.06	86823
2025-05-06	GERN	1.325	0.08	0.16	87161
2025-05-07	GERN	1.315	0.08	0.80	89446
2025-05-08	GERN	1.26	0.14	0.04	101447
2025-05-09	GERN	1.18	0.14	0.02	101349
2025-05-12	GERN	1.28	0.14	0.02	102169
2025-05-13	GERN	1.2	0.14	0.24	102330
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	GERN	1.32	60.4	81.9	-0.09
2025-04-15	GERN	1.25	60.4	83.1	-0.09
2025-04-16	GERN	1.25	60.4	78.1	-0.09
2025-04-17	GERN	1.27	60.4	73.8	-0.09
2025-04-18	GERN	1.27	60.4	76.8	-0.09
2025-04-21	GERN	1.35	60.4	69.1	-0.09
2025-04-22	GERN	1.41	60.4	71.5	-0.09
2025-04-23	GERN	1.39	60.4	78.3	-0.09
2025-04-24	GERN	1.41	60.4	73.3	-0.09
2025-04-25	GERN	1.42	60.4	77.1	-0.09
2025-04-28	GERN	1.40	60.4	78.3	-0.09
2025-04-29	GERN	1.38	60.4	78.4	-0.09
2025-04-30	GERN	1.40	60.4	75.1	-0.09
2025-05-01	GERN	1.43	60.4	75.0	-0.09
2025-05-02	GERN	1.38	60.4	80.8	-0.09
2025-05-05	GERN	1.42	60.4	73.4	-0.09
2025-05-06	GERN	1.32	60.4	84.9	-0.09
2025-05-07	GERN	1.31	60.4	77.7	-0.09
2025-05-08	GERN	1.26	60.4	81.3	-0.09
2025-05-09	GERN	1.18	60.4	85.8	-0.13
2025-05-12	GERN	1.28	60.4	68.0	-0.13
2025-05-13	GERN	1.20	66.5	49.0	-0.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	GERN	0.33	3.15	10.02
2025-04-15	GERN	0.33	3.15	10.02
2025-04-16	GERN	0.33	3.15	10.02
2025-04-17	GERN	0.33	3.15	10.02
2025-04-18	GERN	0.33	3.15	10.02
2025-04-21	GERN	0.33	2.86	10.02
2025-04-22	GERN	0.33	2.86	10.02
2025-04-23	GERN	0.33	2.86	10.02
2025-04-24	GERN	0.33	2.86	10.02
2025-04-25	GERN	0.33	2.86	10.02
2025-04-28	GERN	0.33	2.85	10.41
2025-04-29	GERN	0.33	2.85	10.41
2025-04-30	GERN	0.33	2.85	10.41
2025-05-01	GERN	0.33	2.85	10.41
2025-05-02	GERN	0.33	2.85	10.41
2025-05-05	GERN	0.33	3.75	10.41
2025-05-06	GERN	0.33	3.75	10.41
2025-05-07	GERN	0.33	3.75	10.41
2025-05-08	GERN	0.33	3.75	10.41
2025-05-09	GERN	0.33	3.75	10.41
2025-05-12	GERN	0.33	2.58	10.68
2025-05-13	GERN	0.36	2.58	10.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

0.36

Institutional Transactions

2.58

Beta

0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

77.5

Max Drawdown 5-Year %

-76.8

Target Price

3.69

P/E

Forward P/E

PEG

P/S

6.57

P/B

2.85

P/Free Cash Flow

EPS

-0.21

Average EPS Est. Cur. Y

-0.13

EPS Next Y. (Est.)

-0.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-119.54

Relative Volume

0.69

Return on Equity vs Sector %

-75.5

Return on Equity vs Industry %

-58.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

Geron Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 229

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

stock quote shares GERN – Geron Corporation Stock Price stock today

news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch GERN – Geron Corporation yahoo finance google finance

stock history GERN – Geron Corporation invest stock market

stock prices GERN premarket after hours

ticker GERN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: GERN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y